Biotech News
GSK enters agreement to acquire Nuvalent, Inc.
Acquisition expected to be accretive to sales & core operating profit in 2027 & core EPS in 2029 inclusive of synergies and reprioritisation
Open original release
Related news
No closely related headlines were available from the latest feed snapshot.
GSK plc
GSK plc is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Recent company news
GSKGSK plc2026-06-12 02:09:41 EST
GSK’s momelotinib granted Orphan Drug Designations in the US and EU for VEXAS syndrome
GSKGSK plc2026-05-28 12:42:45 EST
Bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic hepatitis B
GSKGSK plc2026-05-26 17:15:19 EST
GSK to showcase long-term outcomes and pipeline expansion with latest oncology research at ASCO and EHA
GSKGSK plc2026-05-18 10:09:39 EST
GSK’s RSV vaccine, Arexvy, receives expanded approval in Japan for adults aged 18–59 at increased risk
Stock data
- Close
- —
- Market cap
- —
- Exchange
- NYSE
- Sector
- Biotechnology
- Location
- United States